Ivermectin, Fenbendazole and Mebendazole in Cancer: 2024 Peer-Reviewed Protocol in Cancer

Source: www.onedaymd.com/2024/10/ivermectin-fenbendazole-and-mebendazole.html?fbclid=IwY2xjawIB55BleHRuA2FlbQIxMAABHUErLDLHQYFRw28q1apDNpnsPtboQidU4H6Ymj1h0irIuT9CX_IuiqJ_Eg_aem_WfzOGitkdaOrYDfwr7c9ZA
By Editorial Team - January 26, 2025

We are pleased to announce that the first-of-its-kind protocol utilizing Ivermectin, Mebendazole, and Fenbendazole for cancer treatment has been peer-reviewed and officially published on September 19, 2024.

Spearheaded by leading researchers like Dr. Ilyes Baghli, Dr. Pierrick Martinez, and the FLCCC’s Dr. Paul Marik, this groundbreaking protocol harnesses the untapped power of Ivermectin, Mebendazole, and Fenbendazole, known for their effectiveness against parasites. Now, these drugs are showing potential to battle cancer, marking the dawn of a new treatment evolution.

This trio of repurposed drugs has been shown to disrupt the growth of cancer cells, particularly by targeting microtubules, the essential structures that allow cancer to multiply uncontrollably. What makes this protocol even more potent is the synergistic effect when these drugs are used together, creating a powerful new affordable weapon against cancer.

According to oncologist Dr William Makis:

“This paper is the FIRST peer-reviewed and Published paper in the world to propose a Cancer Treatment Protocol based on the incredible properties of IVERMECTIN, MEBENDAZOLE and FENBENDAZOLE. This was truly a labor of love.

My thanks to lead authors Ilyes Baghli and Pierrick Martinez for their incredible inspired work, FLCCC’s Dr. Paul Marik for his extensive work on repurposed drugs and every co-author who worked hard to bring this paper to life.

I hope that this paper lays the groundwork for a brand new future for Cancer Treatment”.

See the link at the top for the full paper and see also:

covid19.onedaymd.com/2022/05/treatment-for-post-vaccine-syndrome-i.html

and

covid19.onedaymd.com/2023/03/dr-peter-mccullough-prescription-and.html ,

with therein:

Autopsy Proven Fatal COVID-19 Vaccine-Induced Myocarditis (3) claimed the top spot in the 'Medicine and Pharmacology' category, specifically focusing on cardiac and cardiovascular systems. This research paper delves into a critical issue surrounding COVID-19 vaccination — the potential risk of myocarditis, particularly in cases where it leads to fatal outcomes.



Lees verder in de categorie Artikelen | Terug naar homepage | Lees de introductie